Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05280730 · ClinicalTrials.gov registry record
Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy
A clinical trial, sponsored by Virginia Commonwealth University.
- Completed
- Registry status
- 50
- Enrollment target
NCT05280730 is a clinical trial that has completed, run by Virginia Commonwealth University. The registered enrollment target is 50 participants.
The verdict
NCT05280730 has completed, sponsored by Virginia Commonwealth University.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
Duchenne Muscular Dystrophy is a genetic disease that causes progressive muscle weakness. There is now substantial evidence that boys with this disease do not demonstrate age-related gains in their cognitive skills. The goals of this study are (i) to use a technology-enabled neurobehavioral assessment called National Institutes of Health Toolbox Cognition Battery (NIHTB-CB) to assess brain development over time; (ii) engage with key-stakeholders to understand how neurodevelopmental problems like attention-deficit hyperactivity, autism spectrum affects individuals (and/or) families, so that we can understand meaningful effects of a potential treatment at an individual level, and (iii) to investigate using brain magnetic resonance imaging (MRI) changes in brain connectivity.
Interventions
- OTHER No intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-02-02 |
| Est. Completion | 2024-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05280730
The ClinicalTrials.gov registry entry for NCT05280730 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Commonwealth University, which has 558 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which No intervention is the first listed.
NCT05280730 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05280730 about?
NCT05280730 is a clinical study titled "Assessment of Neurodevelopmental Needs in Duchenne Muscular Dystrophy". Duchenne Muscular Dystrophy is a genetic disease that causes progressive muscle weakness. There is now substantial evidence that boys with this disease do not demonstrate age-related gains in their cognitive skills. The goals of this study are (i) to use a technology-enabled neurobehavioral assessm...
What is the current status of trial NCT05280730?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2022-02-02. Estimated completion is 2024-09-30.
What interventions are being tested in trial NCT05280730?
The interventions under investigation include: No intervention (OTHER).
Who is sponsoring clinical trial NCT05280730?
This trial is sponsored by Virginia Commonwealth University, which has 558 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.